Freeline Therapeutics

-$0.08 (-2.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FRLN and other ETFs, options, and stocks.

About FRLN

Freeline Therapeutics Holdings Plc operates as holding company whose subsidiaries provide biotechnology services. It develops gene therapies for bleeding and other debilitating disorders.

CEO
Michael J. Parini
Employees
235
Headquarters
Stevenage, Hertfordshire
Founded
2020

FRLN Key Statistics

Market Cap
115.23M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
58.76K
High Today
$3.32
Low Today
$3.18
Open Price
$3.31
Volume
67.66K
52 Week High
$18.88
52 Week Low
$2.92

FRLN Earnings

-$1.12
-$0.75
-$0.37
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure